- Home
- BHB vs TOVX Comparison
BHB vs TOVX Comparison
Compare BHB & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHB | TOVX |
|---|---|---|
| Founded | 1887 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 583.8M | 14.7M |
| IPO Year | 1995 | 2012 |
Fundamental Metrics
Financial Performance| Metric | BHB | TOVX |
|---|---|---|
| Price | $37.65 | $0.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $37.00 | $1.00 |
| AVG Volume (30 Days) | 98.7K | ★ 11.2M |
| Earning Date | 04-21-2026 | 05-13-2026 |
| Dividend Yield | ★ 3.95% | N/A |
| EPS Growth | N/A | ★ 89.07 |
| EPS | ★ 0.81 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.68 | N/A |
| Revenue Next Year | $3.66 | N/A |
| P/E Ratio | $46.09 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $28.06 | $0.16 |
| 52 Week High | $37.41 | $0.86 |
Technical Indicators
Market Signals| Indicator | BHB | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 68.86 | 40.32 |
| Support Level | $33.85 | $0.18 |
| Resistance Level | N/A | $0.28 |
| Average True Range (ATR) | 0.98 | 0.03 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 86.89 | 10.98 |
Price Performance
Historical ComparisonAbout BHB Bar Harbor Bankshares Inc.
Bar Harbor Bankshares Inc is a bank holding company along with its subsidiaries that offers a full range of financial services products, brokerage services through third-party brokerage arrangements, and also trust and investment management services to individuals, businesses, non-profit organizations, and municipalities. Its products and services consist of checking, deposits, cards, mobile banking, online services, loans, merchant services, trust, fiduciary services, investment planning, education funding, and individual retirement planning.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.